Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Naung Latt Htun: High Clinical Suspicion in Acquired Hemophilia A is Essential
Apr 16, 2026, 09:09

Naung Latt Htun: High Clinical Suspicion in Acquired Hemophilia A is Essential

Naung Latt Htun, Internal Medicine Doctor at Ministry of Health Brunei Darussalam, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:

”Excited to share that our latest case report has been published in Cureus Journal of Medical Science!

Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies

In this paper, we present two rare and clinically challenging cases of AHA – an uncommon but potentially life-threatening autoimmune bleeding disorder caused by factor VIII inhibitors.

Key highlights:

  • AHA can present with unexplained bleeding and isolated prolonged aPTT
  • Underlying causes can be diverse – including malignancy, autoimmune conditions, and infections
  • Coexistence with antiphospholipid antibodies creates a complex paradox of bleeding vs thrombosis
  • Early recognition and a dual management approach (bleeding control plus inhibitor eradication) are critical

These cases emphasize the importance of maintaining a high index of suspicion when evaluating unexplained bleeding, especially in patients with comorbid conditions.

Proud to have worked with an excellent team on this publication!”

Title: Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies

Authors: Naung Latt Htun, Hsan Theingi Win, Mohammad Abdullah, Hnin Kay Khine Oo, Dilip Thottacherry

Read the Full Article on Cureus Journal of Medical Science

Naung Latt Htun: High Clinical Suspicion in Acquired Hemophilia A is Essential

Stay updated on all scientific advances with Hemostasis Today.